Fatty Liver Disease and LFT Testing Guide - healthcare nt sickcare

Fatty Liver Disease and LFT Testing Guide

Experiencing persistent fatigue, unexplained abdominal discomfort, weight gain despite normal eating, or general weakness are primary symptoms potentially indicating fatty liver disease requiring liver function testing. Fatty liver disease (hepatic steatosis — a condition where excess fat accumulates in liver cells exceeding 5–10% of liver weight, causing inflammation, scarring, and potentially progressing to cirrhosis or liver failure) affects 25–30% of Indian population particularly those with obesity, diabetes, high cholesterol, or metabolic syndrome, making Liver Function Tests (LFT measuring enzymes ALT, AST, ALP, GGT, and proteins bilirubin, albumin indicating liver health) essential for early detection, monitoring progression, and guiding treatment through lifestyle modifications or medications preventing serious complications.

Since 2007, healthcare nt sickcare has provided comprehensive liver function testing to over 2,600 families across Pune through NABL-accredited laboratory partnerships, offering complete LFT panels, specialized fatty liver profiles, and related tests with convenient home sample collection, affordable transparent pricing, and results delivered within 24–48 hours. This detailed guide explains what fatty liver disease is, symptoms and causes, how LFT testing diagnoses the condition, additional diagnostic methods including ultrasound and FibroScan, treatment strategies reversing fatty liver, and convenient testing options in Pune covering Aundh, Baner, Kothrud, Wakad, and Hinjewadi.

What Is Fatty Liver Disease?

Fatty liver disease occurs when excess fat accumulates in liver cells potentially causing inflammation and progressive damage.

Fatty liver disease, also known as hepatic steatosis, is a condition where triglycerides (fat molecules) accumulate in liver cells (hepatocytes) exceeding normal levels of 5–10% of liver weight by volume. There are two main types — Alcoholic Fatty Liver Disease (AFLD) caused by excessive alcohol consumption damaging liver cells and causing fat accumulation, and Non-Alcoholic Fatty Liver Disease (NAFLD) affecting people who drink little or no alcohol, instead caused by obesity, insulin resistance, diabetes, high cholesterol, or metabolic syndrome. NAFLD is further classified into simple fatty liver (steatosis without inflammation — usually benign with good prognosis) and Non-Alcoholic Steatohepatitis (NASH — fatty liver with inflammation and liver cell damage potentially progressing to fibrosis, cirrhosis, liver failure, or hepatocellular carcinoma). According to medical research, fatty liver disease affects 25–30% of Indian population, with prevalence rising to 50–60% in individuals with obesity or type 2 diabetes, making it one of the most common liver conditions worldwide. The condition develops gradually over years, often remaining silent without symptoms until significant liver damage occurs, emphasizing the importance of regular liver function testing particularly for high-risk individuals with obesity, diabetes, or metabolic syndrome. Learn more about comprehensive liver disease testing approaches.

Book Laboratory Diagnostics Tests in Pune

healthcare nt sickcare offers diagnostics tests and packages with home sample collection and direct walk-in facility.

Symptoms and Causes of Fatty Liver Disease

Fatty liver often presents no symptoms initially but may cause fatigue, abdominal discomfort, or weakness as damage progresses.

Common Symptoms of Fatty Liver Disease

Most people with fatty liver disease experience no symptoms in early stages, making screening essential.

Simple fatty liver (steatosis without inflammation) typically causes no symptoms at all, with the condition discovered incidentally during blood tests for other reasons or imaging studies ordered for unrelated complaints. As fatty liver progresses to NASH (Non-Alcoholic Steatohepatitis with inflammation and cell damage) or advances towards cirrhosis, symptoms may gradually develop including persistent fatigue or low energy not improving with rest, general weakness or feeling unwell, vague abdominal discomfort or fullness particularly in upper right abdomen under ribs where liver is located, unexplained weight loss despite normal eating in advanced disease, and mental confusion or difficulty concentrating indicating severely impaired liver function. Advanced fatty liver disease progressing to cirrhosis causes more severe symptoms including jaundice (yellowing of skin and whites of eyes from bilirubin buildup), abdominal swelling from fluid accumulation (ascites), leg swelling (oedema), easy bruising or bleeding from impaired clotting factor production, enlarged liver or spleen palpable during physical examination, and spider-like blood vessels visible on skin (spider angiomas). Because early fatty liver produces no symptoms, individuals with risk factors require regular liver function testing detecting abnormalities before symptoms appear when interventions are most effective preventing progression.

Major Causes and Risk Factors

Fatty liver disease results primarily from metabolic factors, obesity, diabetes, and high cholesterol levels.

Non-Alcoholic Fatty Liver Disease (NAFLD) develops from multiple interrelated factors including obesity particularly central obesity with excess abdominal fat (most significant risk factor affecting 70–80% of NAFLD patients), insulin resistance and type 2 diabetes impairing glucose metabolism and promoting fat storage in liver, dyslipidaemia with high triglycerides (above 150 mg/dL), low HDL cholesterol (below 40 mg/dL men, below 50 mg/dL women), or high LDL cholesterol contributing to fat accumulation, metabolic syndrome (cluster of conditions including abdominal obesity, insulin resistance, hypertension, dyslipidaemia), rapid weight loss paradoxically causing temporary fatty liver as fat is mobilized faster than liver can process, poor diet high in refined carbohydrates, sugary beverages, saturated fats, and processed foods whilst lacking vegetables and whole grains, sedentary lifestyle with minimal physical activity reducing fat oxidation, certain medications including corticosteroids, tamoxifen, methotrexate, and some antiretroviral drugs, polycystic ovary syndrome (PCOS) in women associated with insulin resistance, sleep apnoea causing intermittent oxygen deprivation affecting liver metabolism, and inherited genetic disorders like Wilson's disease (copper accumulation) or alpha-1 antitrypsin deficiency. Alcoholic Fatty Liver Disease (AFLD) results from excessive alcohol consumption — typically more than 30 grams daily for women or 40 grams daily for men (approximately 2–3 standard drinks) — directly toxic to liver cells promoting fat accumulation, inflammation, and progressive damage potentially leading to alcoholic hepatitis or cirrhosis.

How to Test for Fatty Liver Disease in Pune?

Fatty liver diagnosis combines medical history, physical examination, liver function blood tests, and imaging studies.

Liver Function Tests (LFT) — Primary Blood Testing

LFT measures liver enzymes and proteins indicating liver health, inflammation, or damage from fatty liver disease.

Liver Function Tests form the foundation of fatty liver screening measuring multiple parameters including ALT (alanine aminotransferase — liver-specific enzyme, normal below 40 U/L, elevated 2–5 times normal in NAFLD indicating liver cell damage), AST (aspartate aminotransferase — found in liver, heart, muscles, normal below 40 U/L, elevated in liver disease though less specific than ALT), AST/ALT ratio (ratio below 1 suggests NAFLD whilst ratio above 2 suggests alcoholic liver disease or advanced fibrosis), ALP (alkaline phosphatase — normal 30–120 U/L, elevated in bile duct obstruction though usually normal in uncomplicated fatty liver), GGT (gamma-glutamyl transferase — sensitive alcohol marker and bile duct enzyme, normal below 60 U/L, elevated in alcoholic liver disease and NASH), total bilirubin (yellow pigment from red blood cell breakdown, normal below 1.2 mg/dL, elevated causing jaundice indicating advanced liver disease or bile duct obstruction), albumin (major liver-produced protein, normal 3.5–5.5 g/dL, low levels indicate chronic liver disease with impaired synthetic function), and total protein (normal 6–8 g/dL including albumin and globulins). In early fatty liver disease, liver enzymes may be only mildly elevated (1.5–2 times normal) or even completely normal despite fat accumulation visible on ultrasound, whilst NASH typically causes more significant elevations (2–5 times normal). Progressive liver damage eventually impairs synthetic function causing low albumin and prolonged prothrombin time (PT) indicating poor clotting factor production. Book comprehensive Liver Function Test in Pune with home sample collection. Read our detailed guide on understanding AST and ALT in blood tests.

Additional Blood Tests for Fatty Liver Assessment

Comprehensive fatty liver evaluation includes tests assessing metabolic health, diabetes risk, and causes of liver disease.

Beyond standard LFT, additional blood tests provide essential information including Complete Blood Count (CBC) detecting anaemia from chronic disease or bleeding, elevated white blood cells suggesting infection or inflammation, and low platelets indicating advanced liver disease with portal hypertension. Lipid Profile measures total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides — dyslipidaemia is both a cause and consequence of fatty liver requiring monitoring and treatment. Fasting Blood Glucose and HbA1c screen for diabetes or prediabetes — insulin resistance drives fatty liver development whilst fatty liver worsens diabetes creating vicious cycle. Fasting Insulin and HOMA-IR (homeostatic model assessment of insulin resistance) quantify insulin resistance severity correlating with NAFLD risk and progression. Iron Studies (serum iron, ferritin, transferrin saturation, TIBC) detect iron overload (hemochromatosis) or elevated ferritin from inflammation — high iron accelerates liver damage in fatty liver disease. Hepatitis Testing (Hepatitis B surface antigen, Hepatitis C antibody) rules out viral hepatitis mimicking or coexisting with fatty liver. Autoimmune Markers (ANA, anti-smooth muscle antibody, anti-LKM) exclude autoimmune hepatitis potentially confused with NASH. Alpha-Fetoprotein (AFP tumor marker) screens for hepatocellular carcinoma in advanced disease. Prothrombin Time (PT/INR) and Platelets assess liver synthetic function and portal hypertension — prolonged PT and low platelets indicate advanced fibrosis or cirrhosis. Our Hepatic Steatosis Profile combines essential tests for comprehensive fatty liver assessment.

Imaging Studies — Ultrasound, CT, MRI, FibroScan

Imaging visualizes fat accumulation in liver and assesses severity, fibrosis, and complications.

Liver Ultrasound is the first-line imaging test for detecting fatty liver — inexpensive, widely available, non-invasive, and radiation-free, using sound waves to assess liver echogenicity (brightness) which increases with fat accumulation creating characteristic "bright liver" appearance. Ultrasound can distinguish simple fatty liver from more advanced disease showing liver enlargement, irregular contours suggesting cirrhosis, or abnormal blood flow patterns indicating portal hypertension, though it cannot quantify precise fat percentage or reliably detect early fibrosis. Transient Elastography (FibroScan) is a specialized ultrasound measuring liver stiffness using shear wave velocity — increased stiffness indicates progressive fibrosis or cirrhosis, with results reported as kilopascals (kPa) where normal is below 7 kPa, significant fibrosis 7–9 kPa, advanced fibrosis 9–12 kPa, and cirrhosis above 12 kPa. FibroScan also estimates fat content using Controlled Attenuation Parameter (CAP) with values above 280 dB/m indicating steatosis. CT Scan (computed tomography) creates cross-sectional liver images detecting fat when liver attenuation is lower than spleen, evaluating liver size and contour, detecting lesions or tumours, and assessing vascular anatomy, though CT involves radiation exposure limiting routine use. MRI (magnetic resonance imaging) provides the most detailed, accurate fat quantification using specialized sequences like MR spectroscopy or PDFF (proton density fat fraction), detecting fat deposits as low as 5%, assessing iron overload, detecting focal lesions, and evaluating liver anatomy without radiation, though MRI is expensive limiting widespread screening use.

Liver Biopsy — Gold Standard Diagnosis

Liver biopsy removes tissue sample for microscopic analysis definitively diagnosing fatty liver, NASH, fibrosis stage, and cirrhosis.

Liver biopsy involves inserting a needle through skin into liver under ultrasound guidance, removing small tissue core (1–2 cm length, 1.5 mm diameter), and analysing under microscope to assess fat droplet quantity and distribution, hepatocyte ballooning indicating cell injury, inflammatory cell infiltration suggesting NASH, fibrosis stage (F0 = no fibrosis, F1 = mild perisinusoidal fibrosis, F2 = periportal fibrosis, F3 = bridging fibrosis, F4 = cirrhosis), and sometimes iron deposits, Mallory-Denk bodies, or other features distinguishing disease causes. Biopsy is the gold standard for confirming NASH (versus simple steatosis), staging fibrosis severity guiding prognosis and treatment intensity, excluding other liver diseases with similar presentations, and sometimes required for research studies or clinical trials. However, biopsy is invasive with small complication risks (bleeding, pain, infection, rare liver injury), samples only tiny portion potentially missing heterogeneous disease distribution (sampling error), and is typically reserved for cases where diagnosis is uncertain, non-invasive tests suggest advanced fibrosis, or disease progression despite treatment requires confirmation rather than routine screening of all fatty liver patients.

Book Medical Blood Testing in Pune

healthcare nt sickcare offers medical blood test and medical lab testing with home sample collection and direct walk-in facility.

Treatment and Reversal of Fatty Liver Disease

Fatty liver often reverses with lifestyle modifications including weight loss, diet changes, exercise, and managing underlying conditions.

Lifestyle Modifications — First-Line Treatment

Weight loss, healthy diet, regular exercise, and avoiding alcohol form the foundation of fatty liver treatment.

Weight Loss is the single most effective treatment for NAFLD — losing just 5–7% body weight reduces liver fat content significantly, whilst 10% weight loss can reverse NASH and even improve fibrosis in some patients. Gradual weight loss of 0.5–1 kg weekly through caloric restriction and increased physical activity is recommended, avoiding crash diets or very rapid weight loss (over 1.5 kg weekly) which paradoxically worsens fatty liver by mobilizing fat faster than liver can process. Dietary Modifications emphasizing Mediterranean diet pattern rich in vegetables, fruits, whole grains, legumes, nuts, olive oil, and fish whilst limiting red meat, processed foods, refined carbohydrates, sugary beverages, and saturated fats improves liver enzymes and reduces liver fat within 6–12 weeks. Specific dietary strategies include reducing total carbohydrate intake particularly refined sugars and simple carbohydrates increasing triglyceride synthesis, limiting fructose consumption from sugary drinks and processed foods (fructose is preferentially metabolized in liver promoting fat accumulation), increasing dietary fiber from vegetables and whole grains improving insulin sensitivity, consuming omega-3 fatty acids from fatty fish (salmon, mackerel, sardines) or supplements reducing liver inflammation, and avoiding trans fats completely as they worsen insulin resistance and liver fat. Regular Physical Activity — at least 150 minutes weekly moderate-intensity aerobic exercise (brisk walking, cycling, swimming) plus twice-weekly resistance training — reduces liver fat independent of weight loss, improves insulin sensitivity, reduces inflammation, and prevents disease progression. Alcohol Avoidance is essential for all patients with fatty liver disease as even moderate alcohol consumption (1–2 drinks daily) accelerates liver damage in individuals with existing NAFLD, significantly worsening fibrosis progression and increasing cirrhosis risk. Discover evidence-based liver detox foods and drinks supporting liver health.

Managing Underlying Conditions

Treating diabetes, controlling cholesterol, and managing metabolic syndrome components prevents fatty liver progression.

Diabetes Management through glucose control with medications (metformin, GLP-1 agonists, SGLT2 inhibitors), dietary modifications, and regular physical activity reduces liver fat accumulation and prevents NASH progression — maintaining HbA1c below 7% is essential. Cholesterol Control using statins to lower LDL cholesterol and fibrates to reduce triglycerides improves dyslipidaemia driving fatty liver whilst statins appear safe in liver disease contrary to previous concerns. Blood Pressure Management maintaining values below 130/80 mmHg using ACE inhibitors or ARBs protects liver and reduces cardiovascular complications. Metabolic Syndrome Treatment addressing all components (abdominal obesity, insulin resistance, hypertension, dyslipidaemia) through integrated lifestyle interventions and medications when necessary provides comprehensive protection against fatty liver progression. Sleep Apnoea Treatment with CPAP (continuous positive airway pressure) therapy reduces intermittent hypoxia contributing to liver inflammation and insulin resistance.

Medications for Fatty Liver Disease

No medications are specifically approved for fatty liver, though several show promise in clinical trials.

Vitamin E (alpha-tocopherol) at high doses (800 IU daily) has demonstrated efficacy in non-diabetic NASH patients reducing liver inflammation and improving histology in clinical trials, though long-term safety concerns including increased prostate cancer risk in men and haemorrhagic stroke require consideration. Pioglitazone (insulin-sensitizing medication) improves liver histology in NASH patients with or without diabetes, though side effects including weight gain, fluid retention, bone loss, and bladder cancer risk limit use to carefully selected patients. GLP-1 Receptor Agonists (liraglutide, semaglutide) originally developed for diabetes show promise reducing liver fat, inflammation, and fibrosis whilst promoting weight loss, with ongoing clinical trials evaluating efficacy. SGLT2 Inhibitors (empagliflozin, dapagliflozin) for diabetes also reduce liver fat and enzymes. Obeticholic Acid (FXR agonist) showed fibrosis improvement in clinical trials though liver enzyme elevations and pruritus (itching) limited tolerability. Statins are safe in fatty liver disease and recommended for cardiovascular risk reduction in appropriate patients. Emerging therapies under investigation include FGF21 analogues, thyroid hormone receptor agonists, and combination treatments targeting multiple pathways. Currently, no medication receives regulatory approval specifically for NASH treatment, making lifestyle modification the cornerstone of therapy.

Frequently Asked Questions About Fatty Liver Testing

The best way to prevent fatty liver disease is maintaining a healthy body weight through balanced diet and regular physical activity, as obesity is the most significant risk factor affecting 70–80% of NAFLD patients. Specific prevention strategies include achieving and maintaining BMI below 25 (or below 23 for Indians due to higher body fat percentage at lower BMI), engaging in at least 150 minutes weekly of moderate-intensity aerobic exercise like brisk walking, cycling, or swimming plus twice-weekly resistance training, consuming Mediterranean diet pattern rich in vegetables, fruits, whole grains, legumes, nuts, fish, and olive oil whilst limiting red meat, processed foods, refined carbohydrates, and sugary beverages, avoiding or strictly limiting alcohol consumption as even moderate drinking (1–2 drinks daily) increases fatty liver risk particularly in individuals with other risk factors, preventing or managing type 2 diabetes through glucose control with HbA1c below 7% as diabetes dramatically increases NAFLD risk and accelerates progression, controlling cholesterol and triglycerides maintaining LDL below 100 mg/dL, HDL above 50 mg/dL, and triglycerides below 150 mg/dL, managing blood pressure below 130/80 mmHg, getting adequate sleep 7–9 hours nightly as sleep deprivation worsens insulin resistance, and undergoing regular health screening with liver function tests, glucose, lipid profile, and liver ultrasound particularly if risk factors present enabling early detection when interventions are most effective preventing progression to advanced disease.
Yes, simple fatty liver (steatosis without inflammation) can often be reversed completely through lifestyle modifications, and even Non-Alcoholic Steatohepatitis (NASH with inflammation and liver cell damage) can improve significantly with aggressive intervention though fibrosis reversal is slower and less predictable. Research shows that losing 5–7% of body weight reduces liver fat content substantially, whilst 10% weight loss can resolve NASH in up to 90% of patients and even improve fibrosis in 45% of cases. Reversal requires sustained lifestyle changes including gradual weight loss of 0.5–1 kg weekly through caloric restriction avoiding crash diets, Mediterranean diet emphasizing vegetables, whole grains, lean proteins, healthy fats whilst eliminating sugary beverages, processed foods, and refined carbohydrates, regular exercise at least 150 minutes weekly moderate-intensity aerobic activity plus resistance training, complete alcohol avoidance as even moderate consumption prevents reversal, optimal diabetes control maintaining HbA1c below 7%, and cholesterol management with statins when indicated. Improvement timeline varies — liver enzymes typically normalise within 3–6 months, liver fat content reduces measurably on ultrasound or MRI within 6–12 months, and fibrosis improvement (when it occurs) takes 1–2 years of sustained intervention. Advanced cirrhosis (stage F4 fibrosis) cannot reverse though progression may stop with aggressive treatment, emphasizing the importance of early detection and intervention before irreversible scarring develops through regular liver function testing and prompt action when abnormalities appear.
The timeline for reversing fatty liver disease depends on disease severity, how aggressively lifestyle modifications are implemented, and individual metabolic factors, but most patients see measurable improvement within 3–12 months of sustained intervention. Liver enzyme normalization (ALT, AST returning to normal ranges) typically occurs within 3–6 months of consistent weight loss, dietary changes, and exercise, providing early encouragement that interventions are working. Liver fat reduction becomes measurable on ultrasound or MRI scans within 6–12 months, with simple steatosis potentially resolving completely whilst NASH shows significant improvement though inflammation may persist longer. Fibrosis improvement (when it occurs) is the slowest component, typically requiring 1–2 years of sustained treatment to demonstrate measurable reduction in liver stiffness on FibroScan or histological improvement on repeat liver biopsy, and advanced fibrosis (F3) or cirrhosis (F4) may not reverse at all though progression can stop. Most benefit comes from first 5–10% weight loss achieved in initial 6 months — patients losing 10% body weight within 6–12 months show the greatest liver improvement including NASH resolution and fibrosis regression. Maintaining improvements requires permanent lifestyle changes as weight regain or return to previous unhealthy habits allows fatty liver to recur within months, emphasizing that fatty liver reversal is not a temporary "fix" but rather adoption of sustainable healthy lifestyle preventing recurrence. Regular monitoring with liver function tests every 3–6 months during active treatment and every 6–12 months after improvement tracks progress and ensures sustained success.
Fatty liver disease is primarily diagnosed through Liver Function Tests (LFT) measuring liver enzymes including ALT (alanine aminotransferase — liver-specific enzyme elevated 2–5 times normal in NAFLD), AST (aspartate aminotransferase — elevated in liver disease), ALT/AST ratio (ratio below 1 suggests NAFLD whilst ratio above 2 suggests alcoholic liver disease), GGT (gamma-glutamyl transferase — elevated in alcoholic liver disease and bile duct problems), alkaline phosphatase (usually normal in uncomplicated fatty liver), bilirubin (elevated only in advanced disease causing jaundice), and albumin (low levels indicate chronic liver disease with impaired function). However, it's important to understand that liver enzymes can be completely normal despite significant fat accumulation visible on ultrasound — up to 50% of fatty liver patients have normal ALT/AST — so normal LFT doesn't exclude fatty liver disease. Comprehensive fatty liver assessment includes Complete Blood Count detecting anaemia or low platelets suggesting advanced disease, Lipid Profile measuring cholesterol and triglycerides (dyslipidaemia both causes and results from fatty liver), Fasting Glucose and HbA1c screening for diabetes driving fatty liver development, Iron Studies detecting iron overload accelerating liver damage, Hepatitis B and C testing ruling out viral hepatitis, and sometimes specialized tests like Insulin Level and HOMA-IR quantifying insulin resistance severity. Imaging studies particularly liver ultrasound detecting characteristic "bright liver" appearance provide definitive visualization of fat accumulation confirming clinical suspicion from blood tests, whilst FibroScan assesses liver stiffness indicating fibrosis stage. At healthcare nt sickcare, our Hepatic Steatosis Profile combines essential blood tests for comprehensive fatty liver screening with convenient home sample collection across Pune.
Individuals with fatty liver disease should strictly avoid or severely limit several food categories that worsen liver fat accumulation, inflammation, and disease progression. Alcohol must be completely eliminated as even moderate consumption (1–2 drinks daily) significantly accelerates liver damage in people with existing fatty liver, worsening inflammation, promoting fibrosis progression, and dramatically increasing cirrhosis risk. Sugary beverages including soft drinks, sweetened fruit juices, energy drinks, sweetened coffee/tea, and bubble tea contain high fructose concentrations preferentially metabolized in liver promoting triglyceride synthesis and fat accumulation — eliminating these alone substantially improves fatty liver. Refined carbohydrates and simple sugars including white bread, white rice, pasta, pastries, cakes, cookies, candy, and sweetened cereals rapidly spike blood sugar and insulin driving fat storage in liver. Fried foods and foods high in saturated fats including deep-fried snacks, fried chicken, French fries, burgers, pizza with processed meats, full-fat dairy products, butter, ghee, coconut oil, and palm oil worsen insulin resistance and increase liver inflammation. Trans fats found in partially hydrogenated oils, margarine, commercial baked goods, packaged snacks, and some restaurant fried foods are particularly harmful increasing liver fat, inflammation, and fibrosis progression — these should be completely eliminated. Processed and red meats including bacon, sausages, hot dogs, deli meats, and excessive red meat consumption increase inflammation and are associated with higher NAFLD risk. High-sodium foods including processed foods, canned soups, packaged snacks, restaurant meals, and added table salt worsen fluid retention and should be limited. Instead, emphasize vegetables, fruits, whole grains, legumes, nuts, fatty fish rich in omega-3s, olive oil, and lean proteins supporting liver health and promoting fat reduction.
healthcare nt sickcare provides comprehensive liver function testing in Pune with convenient home blood sample collection eliminating clinic visits, travel time, and waiting periods. We serve extensive areas within 10 km radius from our Aundh base including Aundh, Baner, Wakad, Hinjewadi, Balewadi, Pimple Saudagar, Pashan, Bavdhan, Kothrud, Deccan, and Shivajinagar. To schedule home collection for liver function tests, contact us via phone (+91 97660 60629), WhatsApp, or through our website, specify which tests you need (complete LFT panel, fatty liver profile, or comprehensive liver assessment package), confirm your complete address with landmark, and select preferred collection time (typically 7–10 AM for coordinating with fasting tests when ordered alongside other tests, though LFT itself doesn't require fasting). Our trained phlebotomist arrives at your residence, office, or preferred location with sterile equipment, collects blood sample following safety protocols taking only 2–3 minutes, and immediately transports sample to our NABL-accredited partner laboratory for processing ensuring accurate results meeting international quality standards. Home collection costs Rs 130 (often waived for test packages or orders above Rs 1,001). Digital reports are delivered within 24–48 hours via email and WhatsApp for convenient physician consultation without physical report collection. We also offer walk-in facility at our laboratory for patients preferring direct visits. Our comprehensive Hepatic Steatosis Profile specifically designed for fatty liver screening combines liver enzymes, lipid profile, diabetes screening, and iron studies in one convenient package at discounted pricing compared to ordering tests individually.

Take the Next Step with healthcare nt sickcare

Don't let fatty liver disease silently progress to cirrhosis or liver failure — early detection through liver function testing enables lifestyle interventions reversing fat accumulation, reducing inflammation, and preventing serious complications including liver failure and hepatocellular carcinoma. With 25–30% of Indian population affected by fatty liver disease and prevalence rising with obesity and diabetes epidemics, regular LFT screening particularly for high-risk individuals provides essential health information guiding preventive action. healthcare nt sickcare offers accurate NABL-accredited liver function testing, specialized fatty liver profiles, transparent affordable pricing, convenient home sample collection across Pune, and results within 24–48 hours enabling prompt intervention. As a family-run Pune-based service established since 2007, we prioritise your health through professional testing, personalised service, and compassionate care. Ready to assess your liver health and take control of fatty liver disease before irreversible damage occurs? Book your Liver Function Test or comprehensive Hepatic Steatosis Profile, or contact us at +91 97660 60629 to schedule convenient home sample collection today!

Book LFT Test Now
Disclaimer

The information provided in this blog post is for educational and informational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding fatty liver disease, liver function test interpretation, or treatment decisions. Liver test results must be interpreted by qualified medical practitioners in the context of individual patient symptoms, medical history, imaging findings, risk factors, and other diagnostic information. Normal reference ranges vary between laboratories and must be compared to ranges on your specific laboratory report. Self-diagnosis and self-treatment of fatty liver disease can be dangerous — abnormal liver tests or ultrasound findings require proper medical evaluation including assessment for viral hepatitis, autoimmune liver disease, Wilson's disease, hemochromatosis, and other conditions potentially confused with fatty liver disease. Treatment decisions including medications, dietary modifications, and exercise programmes should be supervised by qualified physicians. healthcare nt sickcare partners with NABL-accredited laboratories for sample processing but does not operate its own laboratory facilities. Images used on test product pages are AI-generated via Google Gemini and Shopify Magic. For more details on our services and policies, please review our Terms of Service and Privacy Policy.

Back to blog

Leave a comment

Please note, comments need to be approved before they are published.